No Data
Esperion to Participate in Upcoming Piper Sandler 36th Annual Healthcare Conference
H.C. Wainwright Maintains Esperion Therapeutics(ESPR.US) With Buy Rating, Maintains Target Price $16
Esperion Highlights New Exploratory Data From CLEAR Outcomes Trial Highlighting Value Of NEXLETOL In Oral Featured Science Session And Multiple Poster Presentations At AHA Scientific Sessions 2024; Exploratory Analysis Reports Patients With PAD Who...
US Manufacturing Index Rises To 43, Highest Since 2020
Esperion Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Express News | Esperion Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
No Data
No Data
Rich2023 : If acquired by a large company, the price could be between $9-15, even $20.
老实和尚 : Look at other stocks, most of them end the day like this. There's nothing special, it may just be a closing mechanism.